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Although exercise-induced growth factors such as Insulin-like 
growth factor-I (IGF-I) are known to affect various aspects of 
physiology in skeletal muscle cells, the molecular mechanism 
by which IGF-I modulates anti-inflammatory effects in these 
cells is presently unknown. Here, we showed that IGF-I stim-
ulation suppresses the expression of toll-like receptor 4 
(TLR4), a key innate immune receptor. A pharmacological in-
hibitor study further showed that PI3K/Akt signaling path-
way is required for IGF-I-mediated negative regulation of 
TLR4 expression. Furthermore, IGF-I treatment reduced the 
expression of various NF-κB-target genes such as TNF-α 
and IL-6. Taken together, these findings indicate that the an-
ti-inflammatory effect of exercise may be due, at least in 
part, to IGF-I-induced suppression of TLR4 and subsequent 
downregulation of the TLR4-dependent inflammatory signal-
ing pathway.
[Immune Network 2011;11(4):223-226]
It is well known that the accumulation of low-grade chronic 
inflammation is common in individuals who live a sedentary 
lifestyle and this condition has been linked to the develop-
ment  of  various  diseases  including  diabetes  and  cardiovas-
cular diseases (1). Increased expression of toll-like receptor 
4  (TLR4),  a  central  innate  immune  receptor,  has  been  ob-
served  in  humans  suffering  from  chronic  inflammatory  dis-
eases such as obesity and type II diabetes (2,3). TLR4 is re-
sponsible  for  recognition  of  pathogens  and  plays  an  im-
portant  role  in  innate  immune  function  and  adaptive  im-
munity (4,5). It is well known that regular exercise is an ef-
fective  countermeasure  against  low-grade  chronic  inflam-
mation (6). It has recently been shown that exercise and reg-
ular physical activity exert anti-inflammatory effects through 
downregulation  of  TLR4  in  the  immune  cells  (7-9). 
    Because skeletal muscle is the largest organ in the human 
body and considered to be an endocrine organ due to the 
production  of  growth  hormones  and  cytokines  in  response 
to exercise stimuli, it is worth examining the modulating ef-
fect of exercise on TLR4 in skeletal muscle cells. However, 
the molecular mechanisms by which exercise modulates TLR4 
signaling pathways are currently unknown. Exercise induces 
various adaptations in skeletal muscle cells in terms of meta-
bolic  and  hormonal  aspects.  Among  them,  increased  levels 
of insulin-like growth factor-I (IGF-I) are one of the most well 
known adaptations induced by various exercise stimuli (10). 
Therefore,  we  investigated  IGF-I  to  determine  if  it  would 
modulate TLR4 gene expression and its downstream signaling 
and subsequently exert an anti-inflammatory effect on skeletal 
muscle cells. To investigate the possible relationship between 
IGF-I and TLR4 expression, we examined the mRNA and pro-
t e i n  l e v e l  o f  T L R 4  i n  t h e  p r e s e n c e  o r  a b s e n c e  o f  I G F - I  
treatment. C2C12 cells were maintained in Dulbecco’s modi-
fied  Eagle’s  medium  (DMEM)  (Welgene,  Korea)  supple-
mented with 10% fetal bovine serum (FBS) (Hyclone, Logan, 
UT)  and  antibiotics  (100  U/ml  penicillin  G  and  100μg/ml 
streptomycin) (Welgene, Korea). For the experiments, C2C12 
myoblasts were plated in six-well culture plates at a density 
of  5×10
5  cells/well  in  growth  medium  (DMEM,  10%  FBS). 
For IGF-I treatment, cells at 90% confluence in DMEM supple-
mented with 2% horse serum (Hyclone, Logan, UT) and anti-
biotics (100 U/ml penicillin G and 100μg/ml streptomycin; IGF-I-induced Down-regulation of TLR4 Signaling
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Figure 1. (A) Effect of different concentrations of IGF-I on TLR4 protein
expression in differentiating C2C12 skeletal muscle cells. Cells were 
treated with IGF-I for 24 hr. (B) TLR4 protein expression in C2C12 
cells treated with IGF-I (200 ng/ml) for 24 hr in the absence or 
presence of LY294002 (100μM) and Wortmannin (50 nM). (C) Cells
were treated with IGF-I (200 ng/ml)＋PD98059 (0.1 or 1.0μM) for 
24 hr. (D) Cells were treated with IGF-I (200 ng/ml)＋SB203580 (0.1
or 1.0μM) for 24 hr.
Welgene, Korea) were treated with IGF-I for 24 hr. The pro-
tein expression levels were then examined by Western blot 
analysis using anti-TLR4 antibody (Santa Cruz Biotechnology, 
Santa Cruz, CA). Anti-α-tubulin was also used to normalize 
the  amounts  of  loading  proteins. 
  The results showed that IGF-I decreased TLR4 protein ex-
pression  in  a  dose-dependent  manner,  indicating that  IGF-I 
has a modulating effect on TLR4 protein expression in C2C12 
skeletal muscle cells (Fig. 1A). The effects of IGF-I are be-
lieved  to  be  mediated  via  signaling  cascades  including  the 
PI3K/Akt  and  MAPK  pathways  (11).  To  determine  if  the 
PI3K/Akt  pathway  is  involved  in  the  IGF-I-mediated  sup-
pression of TLR4 protein expression, IGF-I-treated C2C12 my-
otubes  were  treated  with  specific  PI3K/Akt  inhibitors 
(LY294002 or Wortmannin). As shown in Fig. 1B, IGF-I-in-
duced TLR4 protein suppression was significantly attenuated 
by LY294002 or Wortmannin. These data indicate that IGF-I 
mediates the suppression of TLR4 through PI3K/Akt signaling. 
However,  as  shown  in  Fig.  1C  and  D,  when  we  used 
PD98059 (a specific ERK1/2 inhibitor) or SB203580 (a specific 
inhibitor of the p38 MAPK), we found that TLR4 expression 
levels  were  not  significantly  affected,  indicating  that  p38 
MAPK or ERK1/2 pathways are not involved in IGF-I-induced 
suppression of TLR4 protein expression. To determine if the 
modulating effect of  IGF-I on TLR4 protein  expression  was 
associated  with  TLR4  gene  expression,  TLR4  mRNA  levels 
were determined by real-time PCR. The results showed de-
creases in TLR4 mRNA in IGF-I-treated C2C12 cells of up to 
7 3 %  w i t h  t h e  m a x i m u m  s u p p r e s s i o n  o c c u r r i n g  a t  a n  I G F - I  
concentration of 200 ng/ml (Fig. 2A). As shown in Fig. 2B 
and C, the suppression of TLR4 mRNA following IGF-I treat-
ment in C2C12 cells was significantly attenuated by LY294002 
(200μM) or Wortmannin (100 nM and 200 nM). However, 
the suppressive effect of IGF-I on TLR4 mRNA expression was 
not significantly blocked by SB203580 (Fig. 2D) or PD98059 
(Fig. 2E). Taken together, these results indicate that the sup-
pression  of  TLR4  expression  of  both  mRNA  and  protein  in 
skeletal muscle cells is regulated by IGF-I, and that the neg-
ative-regulatory effect of IGF-I on TLR4 expression is regu-
lated  through  activation  of  the  PI3K/Akt  pathways. 
  It is well known that TLR-mediated signaling activates NF-
κB, which plays a critical role in regulation of the expression 
of pro-inflammatory genes such as tumor necrosis factor-al-
pha (TNF-α) and interleukin-6 (IL-6) (12). Given that IGF-I 
treatment suppresses TLR4 expression, we investigated wheth-
er IGF-I is also involved in the TLR4-mediated NF-κB-depend-
ent  pro-inflammatory  gene  exp r e s s i o n .  A s  b a s a l  c y t o k i n e  
gene  expression  is  chronically  elevated  in  individuals  who 
live a sedentary lifestyle and have many chronic diseases as-
sociated  with  whole  body  chronic  low-grade  inflammation 
(1), we examined the basal expression level of IL-6 and TNF-α 
following IGF-I treatment. The results showed that IGF-I treat-
ment  greatly  attenuated  the  endogenous  expression  of  IL-6 
and TNF-α, indicating that IGF-I exerts an anti-inflammatory 
effect on skeletal muscle cells by reducing the expression of 
pro-inflammatory  cytokines  under  basal  condition  through IGF-I-induced Down-regulation of TLR4 Signaling
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Figure 2. (A) TLR4 mRNA expression determined by real-time PCR in C2C12 myotubes cultured for 24 hr with different concentration of IGF-I. 
Effect of LY294002 (B), Wortmannin (C), SB203580 (D), or PD98059 (E) on IGF-I-mediated TLR4 expression. (F) The mRNA expression level
of IL-6 and TNF-α in C2C12 cells cultured for 24 hr in the absence or presence of IGF-I (200 ng/ml). Target mRNA values are normalized 
to the GAPDH mRNA level for each sample. Samples were analyzed in duplicate in parallel with GAPDH. Values are menas±SE of three 
independent experiments. *p＜0.05 vs. Control.
down-regulation  of  TLR4  expression.  Although  the  exact 
mechanism remains to be elucidated, we can speculate that 
cells having low TLR4 expression are less sensitive to endoge-
nous  inflammation-stimulating  ligands  such  as  heat  shock 
proteins,  which  contributes  low  basal  cytokine  expression. 
  In the present study, we demonstrated that IGF-I treatment 
causes  suppression  of  TLR4  expression  in  differentiating 
C2C12 skeletal muscle cells. Our data provide the first evi-
dence that growth hormone is a potent modulator of TLR4 
expression in skeletal muscle cells. It has been suggested that 
normal inflammatory responses are the natural host responses 
to an acute infection, whereas chronic inflammation is linked 
to many chronic diseases such as heart disease, some cancers, 
and  type  II  diabetes  (2,3,13).  Regular  exercise  has  anti-in-
flammatory  effects  and  protects  against  diseases  associated 
with chronic low-grade systemic inflammation. Skeletal mus-
cle  is  now  considered  an  endocrine  organ  and  affects  in-
flammation throughout the body via the production of pro-in-
flammatory cytokines (14). Therefore, it is possible that the 
IGF-I-induced suppression of TLR4 and cytokine expression 
in  skeletal  muscle  cells  observed  in  the  present  study  may 
provide a mechanistic basis for the anti-inflammatory effect 
of  exercise. 
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